In our study, the stronger APOE4 dosage effect observed in Hispanic/Latino individuals compared to non‐Hispanic Black individuals may reflect differences in ancestry admixture, including varying proportions of Amerindian, African, and European genetic backgrounds, which have been shown to influence APOE4‐associated AD risk.19 This evidence concerns the gene APOE and Alzheimer disease.